Research Paper Volume 12, Issue 16 pp 15995—16020

Neuroprotective effects of p62(SQSTM1)-engineered lactic acid bacteria in Alzheimer’s disease: a pre-clinical study

class="figure-viewer-img"

Figure 5. Proteasome functionality in brain homogenates of 3xTg-AD mice. The ChT-L, T-L, PGPH and BrAAP components of the 20S proteasome and the ChT-L activity of the 26S proteasome were measured using fluorogenic peptides as reported in the Material and Method section (panel A) (*p<0.05, **p<0.01 and ***p<0.001 vs T0, # p<0.05, ## p<0.01 and ###p<0.001 vs C, §p<0.05, §§p<0.01 and §§§p<0.001 vs LAB). Immunodetection of the proteasome substrates p27, p53 and Ub-protein conjugates in brain homogenates of 3xTg-AD mice, T0, C, LAB and p62-LAB groups (panel B) and related densitometry (panel C). GAPDH was used as a control to check equal protein loading (*p<0.05, **p<0.01 and ***p<0.001 vs T0, #p<0.05, ## p<0.01 and ###p<0.001 vs C, §p<0.05 and §§p<0.01 vs LAB).